Brian Boylan

1.3k total citations
24 papers, 886 citations indexed

About

Brian Boylan is a scholar working on Hematology, Immunology and Allergy and Surgery. According to data from OpenAlex, Brian Boylan has authored 24 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 8 papers in Immunology and Allergy and 5 papers in Surgery. Recurrent topics in Brian Boylan's work include Platelet Disorders and Treatments (18 papers), Cell Adhesion Molecules Research (8 papers) and Hemophilia Treatment and Research (6 papers). Brian Boylan is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Cell Adhesion Molecules Research (8 papers) and Hemophilia Treatment and Research (6 papers). Brian Boylan collaborates with scholars based in United States, Czechia and Australia. Brian Boylan's co-authors include Peter J. Newman, Debra K. Newman, Cunji Gao, Vipul Rathore, Joan Cox Gill, Connie H. Miller, Richard H. Aster, Juan Fang, Reema Goel and David A. Wilcox and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Brian Boylan

24 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Boylan United States 16 554 197 173 161 138 24 886
Stephen F. Garner United Kingdom 18 570 1.0× 148 0.8× 79 0.5× 112 0.7× 102 0.7× 54 854
C de la Salle France 19 626 1.1× 324 1.6× 175 1.0× 111 0.7× 245 1.8× 30 1.3k
Kerstin Büchner Germany 9 171 0.3× 146 0.7× 85 0.5× 96 0.6× 205 1.5× 10 1.3k
M. Bérard France 15 225 0.4× 51 0.3× 87 0.5× 77 0.5× 105 0.8× 34 586
Turid M. Pedersen Norway 14 146 0.3× 73 0.4× 78 0.5× 138 0.9× 213 1.5× 24 678
J.J. Ryckewaert France 8 292 0.5× 231 1.2× 76 0.4× 53 0.3× 126 0.9× 9 559
Nicoletta Sorvillo Netherlands 17 221 0.4× 45 0.2× 126 0.7× 49 0.3× 254 1.8× 24 910
KE Arfors United States 9 236 0.4× 561 2.8× 77 0.4× 51 0.3× 221 1.6× 12 1.0k
T D Bartley United States 7 880 1.6× 46 0.2× 35 0.2× 197 1.2× 161 1.2× 8 1.0k
Sabine Blum Switzerland 17 297 0.5× 46 0.2× 76 0.4× 29 0.2× 420 3.0× 59 976

Countries citing papers authored by Brian Boylan

Since Specialization
Citations

This map shows the geographic impact of Brian Boylan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Boylan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Boylan more than expected).

Fields of papers citing papers by Brian Boylan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Boylan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Boylan. The network helps show where Brian Boylan may publish in the future.

Co-authorship network of co-authors of Brian Boylan

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Boylan. A scholar is included among the top collaborators of Brian Boylan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Boylan. Brian Boylan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Payne, Amanda B., et al.. (2022). Stability of specimens for use in the Centers for Disease Control and Prevention assays for factor VIII and IX inhibitors. Research and Practice in Thrombosis and Haemostasis. 6(7). e12806–e12806. 1 indexed citations
2.
Boylan, Brian, et al.. (2021). Manufacturing Control System Development for an In Vitro Diagnostic Product Platform. Processes. 9(6). 975–975. 7 indexed citations
3.
Boylan, Brian, et al.. (2018). Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non‐haemophilic patients. Haemophilia. 24(5). 807–814. 10 indexed citations
4.
Boylan, Brian & Connie H. Miller. (2018). Effects of pre‐analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels. Haemophilia. 24(3). 487–491. 25 indexed citations
5.
Miller, Connie H., Brian Boylan, Amanda B. Payne, et al.. (2015). Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening. American Journal of Hematology. 90(10). 871–876. 7 indexed citations
6.
Miller, Connie H., Brian Boylan, Amy D. Shapiro, et al.. (2013). Comparison of clot‐based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study. Journal of Thrombosis and Haemostasis. 11(7). 1300–1309. 43 indexed citations
7.
Zhi, Huiying, Lubica Rauova, Vincent Hayes, et al.. (2012). Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. Blood. 121(10). 1858–1867. 75 indexed citations
8.
Gao, Cunji, Brian Boylan, Juan Fang, et al.. (2011). Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. Blood. 117(18). 4946–4952. 87 indexed citations
9.
10.
Gao, Cunji, Brian Boylan, Joan Cox Gill, et al.. (2009). Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcγRIIa and the integrin β3 cytoplasmic domain. Journal of Clinical Investigation. 119(3). 504–511. 51 indexed citations
11.
Goel, Reema, Benjamin R. Schrank, Shikha Arora, et al.. (2008). Site-Specific Effects of PECAM-1 on Atherosclerosis in LDL Receptor–Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology. 28(11). 1996–2002. 87 indexed citations
12.
Boylan, Brian, Cunji Gao, Vipul Rathore, et al.. (2008). Identification of FcγRIIa as the ITAM-bearing receptor mediating αIIbβ3 outside-in integrin signaling in human platelets. Blood. 112(7). 2780–2786. 135 indexed citations
13.
Bakchoul, Tamam, Brian Boylan, Ulrich J. Sachs, et al.. (2008). Blockade of maternal anti‐HPA‐1a–mediated platelet clearance by an HPA‐1a epitope–specific F(ab′)2 in an in vivo mouse model of alloimmune thrombocytopenia. Transfusion. 49(2). 265–270. 25 indexed citations
14.
Zhu, Jieqing, Brian Boylan, Bing‐Hao Luo, Peter J. Newman, & Timothy A. Springer. (2007). Tests of the Extension and Deadbolt Models of Integrin Activation. Journal of Biological Chemistry. 282(16). 11914–11920. 53 indexed citations
15.
Newman, Peter J., Richard H. Aster, & Brian Boylan. (2007). Human platelets circulating in mice: applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders. Journal of Thrombosis and Haemostasis. 5. 305–309. 29 indexed citations
16.
Goel, Reema, Brian Boylan, Lynn M. Gruman, et al.. (2007). The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 293(6). G1205–G1214. 34 indexed citations
17.
Boylan, Brian. (2006). "I Am Home" The Feminist Implications of Identity Loss in Haunted House Narratives. 11(1). 4. 1 indexed citations
18.
19.
Kim, Dong-Jin, et al.. (2003). Inactivation of ompR Promotes Precocious Swarming and flhDC Expression in Xenorhabdus nematophila. Journal of Bacteriology. 185(17). 5290–5294. 25 indexed citations
20.
Forst, Steven & Brian Boylan. (2002). Characterization of the pleiotropic phenotype of an ompR strain of Xenorhabdus nematophila. Antonie van Leeuwenhoek. 81(1-4). 43–49. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen F. Garner Breakdown of academic impact, for papers by C de la Salle Breakdown of academic impact, for papers by Kerstin Büchner Breakdown of academic impact, for papers by M. Bérard Breakdown of academic impact, for papers by Turid M. Pedersen Breakdown of academic impact, for papers by J.J. Ryckewaert Breakdown of academic impact, for papers by Nicoletta Sorvillo Breakdown of academic impact, for papers by KE Arfors Breakdown of academic impact, for papers by T D Bartley Breakdown of academic impact, for papers by Sabine Blum
Rankless by CCL
2026